Early research (Phase 1)Looking for participantsNCT05423691What this trial is testingLeading in MPNs Beyond Ruxolitinib in Combo With T-RegsWho this might be right forMyelofibrosis Cellenkos, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07523555What this trial is testingAdaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic MalignanciesWho this might be right forRelapsed/Refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLLRelapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia+4 more Beijing Biotech 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397What this trial is testingChemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantWho this might be right forAcute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT00061620What this trial is testingPhase I Study of Continuous Infusion Schedule of FMdC in Hematologic MalignanciesWho this might be right forHematologic Malignancies M.D. Anderson Cancer Center 19
Early research (Phase 1)Study completedNCT01134120What this trial is testingA Study in Myeloproliferative DisordersWho this might be right forMyeloproliferative DisordersThrombocythemia, EssentialPolycythemia Vera+1 more Eli Lilly and Company 80
Not applicableEnded earlyNCT02042924What this trial is testingPilot Study of Multi-Modality Imaging in Patients With Hematologic MalignanciesWho this might be right forHematologic Malignancy Masonic Cancer Center, University of Minnesota 2
Not applicableStudy completedNCT06576102What this trial is testingEvaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised PatientsWho this might be right forPersistent COVID-19B Cell Malignancies Maddalena Giannella 204
Testing effectiveness (Phase 2)UnknownNCT00750126What this trial is testingAllogeneic Hematopoietic Stem Cell TransplantationWho this might be right forSolid TumorsHematologic Neoplasms University Hospital, Clermont-Ferrand 30
Large-scale testing (Phase 3)Study completedNCT01503515What this trial is testingCaspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell TransplantWho this might be right forFungal InfectionHematopoietic and Lymphoid Cell Neoplasm Children's Oncology Group 292
Early research (Phase 1)Study completedNCT00692926What this trial is testingUnrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood CellsWho this might be right forMDSAnemia, AplasticInborn Errors of Metabolism+2 more Joanne Kurtzberg, MD 37
Not applicableNot Yet RecruitingNCT07551817What this trial is testingThe Effect of Art-Based Intervention on Fatigue, Anxiety, Perception of Nurse Presence, and Quality of Life in Patients With Hematological CancersWho this might be right forArt-based InterventionHematological CancerNurse Presence+3 more Gazi University 52
Testing effectiveness (Phase 2)Ended earlyNCT01799889What this trial is testingStudy to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic MalignanciesWho this might be right forChronic Lymphocytic LeukemiaMantle Cell LymphomaDiffuse Large B-cell Lymphoma+2 more Gilead Sciences 326
Not applicableStudy completedNCT04745416What this trial is testingClinical Characteristics of Patients With Leukemia and COVID-19Who this might be right forLeukemia, AcuteCovid19Leukemia, Lymphoblastic Hospital General de Mexico 30
Large-scale testing (Phase 3)UnknownNCT05175508What this trial is testingAza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDSWho this might be right forAMLMDSOld Age; Debility+1 more The First Affiliated Hospital of Soochow University 180
Testing effectiveness (Phase 2)UnknownNCT02385955What this trial is testingPhase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult PatientsWho this might be right forHematologic Malignancy Seoul National University Hospital 39
Testing effectiveness (Phase 2)Study completedNCT01175785What this trial is testingInfusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+17 more Nohla Therapeutics, Inc. 15
Testing effectiveness (Phase 2)WithdrawnNCT01882374What this trial is testingEfficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood TransplantationWho this might be right forHematologic Malignancies Tarix Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02711852What this trial is testingA Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)Who this might be right forHematologic Malignancy SecuraBio 19
Testing effectiveness (Phase 2)WithdrawnNCT01131247What this trial is testingPH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & OfatumumabWho this might be right forChronic Lymphocytic Leukemia (CLL) Nevada Cancer Institute 37
Not applicableLooking for participantsNCT04841447What this trial is testingMembrane Target Detection for Leukemia TreatmentWho this might be right forHematological Malignancy University of Missouri-Columbia 50